Clinical trial
A Clinical Study of GK01 Cell Therapy in Patients With Gastric Cancer With Peritoneal Metastasis Safety Tolerability and Preliminary Efficacy
NCT07923396 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study of GK01 Cell Therapy in Patients With Gastric Cancer With Peritoneal Metastasis Safety Tolerability and Preliminary Efficacy
- Lead sponsor
- Ruijin Hospital
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- December 31, 2028
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastric cancer (gc)
Lead sponsor's other trials
Ruijin Hospital, most recent start first.
+673 more trials See the organization page
Similar trials
Same condition (Stomach Neoplasms) and phase, most recent start first.
+434 more trials See the condition page